<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>10840228301292</udiDi>
    <basicUdiDi>0840228300034F</basicUdiDi>
    <tradeName>OPTIVE FUSION</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-30T13:39:36.017Z</lastUpdated>
  </row>
  <row>
    <udiDi>10840228301308</udiDi>
    <basicUdiDi>0840228300034F</basicUdiDi>
    <tradeName>OPTIVE FUSION</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-30T13:39:35.999Z</lastUpdated>
  </row>
  <row>
    <udiDi>10840228301315</udiDi>
    <basicUdiDi>0840228300034F</basicUdiDi>
    <tradeName>OPTIVE FUSION</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-30T13:39:35.982Z</lastUpdated>
  </row>
  <row>
    <udiDi>10840228301322</udiDi>
    <basicUdiDi>0840228300034F</basicUdiDi>
    <tradeName>OPTIVE FUSION</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-30T13:39:35.963Z</lastUpdated>
  </row>
  <row>
    <udiDi>10840228301339</udiDi>
    <basicUdiDi>0840228300034F</basicUdiDi>
    <tradeName>OPTIVE FUSION</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-30T13:39:35.940Z</lastUpdated>
  </row>
  <row>
    <udiDi>10840228301346</udiDi>
    <basicUdiDi>0840228300034F</basicUdiDi>
    <tradeName>OPTIVE FUSION</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-30T13:39:35.917Z</lastUpdated>
  </row>
  <row>
    <udiDi>10840228301353</udiDi>
    <basicUdiDi>0840228300034F</basicUdiDi>
    <tradeName>OPTAVA FUSION</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-30T13:39:35.899Z</lastUpdated>
  </row>
  <row>
    <udiDi>10840228301360</udiDi>
    <basicUdiDi>0840228300034F</basicUdiDi>
    <tradeName>OPTIVE FUSION</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-30T13:39:35.881Z</lastUpdated>
  </row>
  <row>
    <udiDi>10840228301377</udiDi>
    <basicUdiDi>0840228300034F</basicUdiDi>
    <tradeName>OPTIVE FUSION</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-30T13:39:35.867Z</lastUpdated>
  </row>
  <row>
    <udiDi>10840228301483</udiDi>
    <basicUdiDi>0840228300034F</basicUdiDi>
    <tradeName>OPTIVE PLUS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-30T13:39:35.815Z</lastUpdated>
  </row>
  <row>
    <udiDi>10840228301490</udiDi>
    <basicUdiDi>0840228300034F</basicUdiDi>
    <tradeName>OPTIVE PLUS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-30T13:39:35.795Z</lastUpdated>
  </row>
  <row>
    <udiDi>10840228301506</udiDi>
    <basicUdiDi>0840228300034F</basicUdiDi>
    <tradeName>OPTIVE PLUS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-30T13:39:35.774Z</lastUpdated>
  </row>
  <row>
    <udiDi>10840228301513</udiDi>
    <basicUdiDi>0840228300034F</basicUdiDi>
    <tradeName>OPTIVE PLUS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-30T13:39:35.754Z</lastUpdated>
  </row>
  <row>
    <udiDi>10840228301520</udiDi>
    <basicUdiDi>0840228300034F</basicUdiDi>
    <tradeName>OPTIVE PLUS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-30T13:39:35.733Z</lastUpdated>
  </row>
  <row>
    <udiDi>10840228301537</udiDi>
    <basicUdiDi>0840228300034F</basicUdiDi>
    <tradeName>OPTIVE PLUS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-30T13:39:35.717Z</lastUpdated>
  </row>
  <row>
    <udiDi>10840228301551</udiDi>
    <basicUdiDi>0840228300034F</basicUdiDi>
    <tradeName>OPTIVE PLUS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-30T13:39:35.700Z</lastUpdated>
  </row>
  <row>
    <udiDi>10840228301568</udiDi>
    <basicUdiDi>0840228300034F</basicUdiDi>
    <tradeName>OPTIVE PLUS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-30T13:39:35.687Z</lastUpdated>
  </row>
  <row>
    <udiDi>10840228301575</udiDi>
    <basicUdiDi>0840228300034F</basicUdiDi>
    <tradeName>OPTIVE PLUS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-30T13:39:35.675Z</lastUpdated>
  </row>
  <row>
    <udiDi>10840228301582</udiDi>
    <basicUdiDi>0840228300034F</basicUdiDi>
    <tradeName>OPTIVE PLUS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-30T13:39:35.658Z</lastUpdated>
  </row>
  <row>
    <udiDi>10840228301599</udiDi>
    <basicUdiDi>0840228300034F</basicUdiDi>
    <tradeName>OPTIVE FUSION</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-30T13:39:35.644Z</lastUpdated>
  </row>
</eudamedExport>